Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

Triple-negative breast cancer (TNBC) is a heterogeneous disease in which the tumors do not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor 2 (HER2). Classical receptor-targeted therapies such as tamoxifen or trastuzumab are therefore unsuitable a...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoury, Manal, Bauerschlag, Dirk, Zeppernick, Felix, von Felbert, Verena, Berges, Nina, Di Fiore, Stefano, Mintert, Isabell, Bleilevens, Andreas, Maass, Nicolai, Bräutigam, Karen, Meinhold-Heerlein, Ivo, Stickeler, Elmar, Barth, Stefan, Fischer, Rainer, Hussain, Ahmad Fawzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342391/
https://www.ncbi.nlm.nih.gov/pubmed/27448975
http://dx.doi.org/10.18632/oncotarget.10705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342391/
https://www.ncbi.nlm.nih.gov/pubmed/27448975
http://dx.doi.org/10.18632/oncotarget.10705

Ejemplares similares